- Home
- CURV vs ANVS Comparison
CURV vs ANVS Comparison
Compare CURV & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURV | ANVS |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.0M | 111.3M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CURV | ANVS |
|---|---|---|
| Price | $1.15 | $2.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $1.59 | ★ $13.50 |
| AVG Volume (30 Days) | 434.1K | ★ 545.8K |
| Earning Date | 03-19-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,039,486,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.94 | $1.11 |
| 52 Week High | $7.19 | $5.50 |
Technical Indicators
Market Signals| Indicator | CURV | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 34.79 |
| Support Level | $1.10 | $2.80 |
| Resistance Level | $1.25 | $3.14 |
| Average True Range (ATR) | 0.11 | 0.25 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 26.79 | 4.43 |
Price Performance
Historical ComparisonAbout CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.